White House Calls for Modernization of Biotechnology Regulations

Biotechnological innovation is potentially subject to a variety of governmental regulations. For example, therapeutics for disease treatment or prevention in humans are subject to review and approval by the Food and Drug Administration (FDA). Innovations relating to crops or livestock may be subject to the Department of Agriculture (USDA). However, the regulations promulgated by these governmental agencies are […]

Continue Reading →

USPTO Issues Updated Guidance on Patent Eligibility

Patent eligibility under 35 U.S.C. § 101 has been an area of significant change in recent years.  Several Supreme Court decisions have changed our understanding of what does and does not qualify for patent protection.  These decisions, in turn, have required a change in the procedures implemented by the USPTO during the examination of patents. […]

Continue Reading →